Jonathan Yong
Stock Analyst at UBS
(2.69)
# 1,903
Out of 5,141 analysts
95
Total ratings
62.96%
Success rate
12.13%
Average return
Main Sectors:
Stocks Rated by Jonathan Yong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OSCR Oscar Health | Upgrades: Neutral | $12 → $17 | $13.23 | +28.50% | 10 | Jan 9, 2026 | |
| EHTH eHealth | Maintains: Neutral | $7 → $5 | $1.48 | +237.84% | 6 | Aug 7, 2025 | |
| CLOV Clover Health Investments | Maintains: Neutral | $4.5 → $3 | $2.02 | +48.51% | 4 | Aug 6, 2025 | |
| EHAB Enhabit | Maintains: Neutral | $15 → $12 | $11.09 | +8.21% | 3 | Aug 11, 2023 | |
| GDRX GoodRx Holdings | Maintains: Neutral | $7 → $8 | $2.47 | +223.89% | 4 | Aug 10, 2023 | |
| CCRN Cross Country Healthcare | Maintains: Neutral | $27 → $26 | $8.61 | +201.97% | 2 | Aug 8, 2023 | |
| HIMS Hims & Hers Health | Reiterates: Outperform | $14 | $15.63 | -10.43% | 3 | Aug 8, 2023 | |
| HSIC Henry Schein | Reiterates: Outperform | $96 | $79.57 | +20.65% | 3 | Aug 8, 2023 | |
| SEM Select Medical Holdings | Maintains: Neutral | $29 → $32 | $15.01 | +113.19% | 3 | Aug 7, 2023 | |
| AMN AMN Healthcare Services | Maintains: Outperform | $115 → $105 | $19.32 | +443.48% | 4 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $76 → $80 | $106.55 | -24.92% | 3 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $247 → $231 | $282.67 | -18.28% | 6 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $27 | $4.74 | +469.62% | 5 | Jul 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $90 → $100 | $224.44 | -55.44% | 2 | Jun 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $430 → $450 | $947.48 | -52.51% | 3 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $15 → $12 | $1.51 | +694.70% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $70 | $5.45 | +1,184.40% | 2 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $17 | $20.64 | -17.64% | 2 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $347 → $350 | $151.00 | +131.79% | 3 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $93 → $95 | $16.79 | +465.81% | 1 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $7 → $8.5 | $1.63 | +423.08% | 2 | Apr 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $41 | $21.99 | +86.45% | 2 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.3 → $8.5 | $3.56 | +138.76% | 2 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $85 | $79.20 | +7.32% | 1 | Feb 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $143 → $146 | $202.41 | -27.87% | 1 | Jan 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $104 → $106 | $43.24 | +145.14% | 3 | Dec 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $129 → $157 | $230.49 | -31.88% | 1 | Nov 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $329 → $368 | $280.31 | +31.28% | 2 | Nov 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $548 → $635 | $189.83 | +234.51% | 2 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $113 → $117 | $76.69 | +52.56% | 2 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $31 → $30 | $18.82 | +59.40% | 1 | May 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $267 → $298 | $532.30 | -44.02% | 1 | Oct 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $88 → $95 | $229.90 | -58.68% | 2 | Oct 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $462 → $495 | $290.00 | +70.69% | 1 | Oct 15, 2021 |
Oscar Health
Jan 9, 2026
Upgrades: Neutral
Price Target: $12 → $17
Current: $13.23
Upside: +28.50%
eHealth
Aug 7, 2025
Maintains: Neutral
Price Target: $7 → $5
Current: $1.48
Upside: +237.84%
Clover Health Investments
Aug 6, 2025
Maintains: Neutral
Price Target: $4.5 → $3
Current: $2.02
Upside: +48.51%
Enhabit
Aug 11, 2023
Maintains: Neutral
Price Target: $15 → $12
Current: $11.09
Upside: +8.21%
GoodRx Holdings
Aug 10, 2023
Maintains: Neutral
Price Target: $7 → $8
Current: $2.47
Upside: +223.89%
Cross Country Healthcare
Aug 8, 2023
Maintains: Neutral
Price Target: $27 → $26
Current: $8.61
Upside: +201.97%
Hims & Hers Health
Aug 8, 2023
Reiterates: Outperform
Price Target: $14
Current: $15.63
Upside: -10.43%
Henry Schein
Aug 8, 2023
Reiterates: Outperform
Price Target: $96
Current: $79.57
Upside: +20.65%
Select Medical Holdings
Aug 7, 2023
Maintains: Neutral
Price Target: $29 → $32
Current: $15.01
Upside: +113.19%
AMN Healthcare Services
Aug 4, 2023
Maintains: Outperform
Price Target: $115 → $105
Current: $19.32
Upside: +443.48%
Aug 4, 2023
Maintains: Outperform
Price Target: $76 → $80
Current: $106.55
Upside: -24.92%
Aug 2, 2023
Maintains: Outperform
Price Target: $247 → $231
Current: $282.67
Upside: -18.28%
Jul 26, 2023
Reiterates: Neutral
Price Target: $27
Current: $4.74
Upside: +469.62%
Jun 12, 2023
Maintains: Neutral
Price Target: $90 → $100
Current: $224.44
Upside: -55.44%
May 12, 2023
Maintains: Outperform
Price Target: $430 → $450
Current: $947.48
Upside: -52.51%
May 5, 2023
Maintains: Neutral
Price Target: $15 → $12
Current: $1.51
Upside: +694.70%
May 4, 2023
Maintains: Neutral
Price Target: $80 → $70
Current: $5.45
Upside: +1,184.40%
Apr 28, 2023
Maintains: Neutral
Price Target: $14 → $17
Current: $20.64
Upside: -17.64%
Apr 28, 2023
Maintains: Outperform
Price Target: $347 → $350
Current: $151.00
Upside: +131.79%
Apr 28, 2023
Maintains: Outperform
Price Target: $93 → $95
Current: $16.79
Upside: +465.81%
Apr 4, 2023
Maintains: Underperform
Price Target: $7 → $8.5
Current: $1.63
Upside: +423.08%
Mar 7, 2023
Reiterates: Outperform
Price Target: $41
Current: $21.99
Upside: +86.45%
Feb 17, 2023
Maintains: Neutral
Price Target: $3.3 → $8.5
Current: $3.56
Upside: +138.76%
Feb 16, 2023
Reiterates: Outperform
Price Target: $85
Current: $79.20
Upside: +7.32%
Jan 25, 2023
Maintains: Neutral
Price Target: $143 → $146
Current: $202.41
Upside: -27.87%
Dec 19, 2022
Maintains: Outperform
Price Target: $104 → $106
Current: $43.24
Upside: +145.14%
Nov 25, 2022
Maintains: Outperform
Price Target: $129 → $157
Current: $230.49
Upside: -31.88%
Nov 7, 2022
Maintains: Outperform
Price Target: $329 → $368
Current: $280.31
Upside: +31.28%
Nov 3, 2022
Maintains: Outperform
Price Target: $548 → $635
Current: $189.83
Upside: +234.51%
Aug 8, 2022
Maintains: Outperform
Price Target: $113 → $117
Current: $76.69
Upside: +52.56%
May 3, 2022
Maintains: Outperform
Price Target: $31 → $30
Current: $18.82
Upside: +59.40%
Oct 25, 2021
Maintains: Outperform
Price Target: $267 → $298
Current: $532.30
Upside: -44.02%
Oct 22, 2021
Maintains: Outperform
Price Target: $88 → $95
Current: $229.90
Upside: -58.68%
Oct 15, 2021
Maintains: Outperform
Price Target: $462 → $495
Current: $290.00
Upside: +70.69%